American Journal of Cardiovascular Drugs
Published by Springer Nature
ISSN : 1175-3277 eISSN : 1179-187X
Abbreviation : Am. J. Cardiovasc. Drug
Aims & Scope
The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures.
The journal includes: Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively).
Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease.
Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
Therapy in practice reviews covering optimum management of specific conditions.
Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine.
Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.
Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content.
In addition, articles published in the American Journal of Cardiovascular Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 3 |
| 2024 | 2.80 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 5934 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 525 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.876 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Endogenous and Exogenous Cardiac Glycosides and their Mechanisms of Action
Citation: 191
Authors: Wilhelm, Georgios
-
Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
Citation: 179
Authors: Jeanne, Hamim, Nobuko, Robert, Frank, Shuquan, George, Minggao
-
Interactions Between Grapefruit Juice and Cardiovascular Drugs
Citation: 166
Authors: David G, George K
-
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
Citation: 158
Authors: Adrian V., Ali, Anitha, A.
-
The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
Citation: 158
Authors: Hong, Xiangyang, Xiuzhen
-
Current Overview on Hypercoagulability in COVID-19
Citation: 140
Authors: Namrata, Saurabh, Divya P., Abutaleb A., Peter A., Girish
-
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Citation: 133
Authors: Peter P., Angelo Maria, Rosaria Vincenza, Dragana, Giuseppa, Manfredi, Maciej